Motivational effects of μ- and κ-opioid agonists following acute and chronic restraint stress: Involvement of dopamine D1 and D2 receptors

Behavioural Brain Research

Volumn 132, Issue 2, 2002, Pages 159-169

  Capriles, Nancy Del Rosario ^a   Cancela, Liliana Marina ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

and Opioid receptors; Bremazocine; Conditioned place preference aversion; D1 and D2 dopamine receptors; Morphine; Restraint stress

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BENZAZEPINE DERIVATIVE; BREMAZOCINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; KAPPA OPIATE RECEPTOR ANTAGONIST; MORPHINE; MU OPIATE RECEPTOR AGONIST; NALOXONE; SULPIRIDE; UNCLASSIFIED DRUG; BENZOMORPHAN DERIVATIVE; DRUG DERIVATIVE; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; NALTREXONE; NARCOTIC AGENT; NARCOTIC ANTAGONIST; NORBINALTORPHIMINE;

ARTICLE; AVERSION; AVERSIVE BEHAVIOR; CONDITIONING; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG EFFECT; IMMOBILIZATION STRESS; MALE; NONHUMAN; PERCEPTIVE THRESHOLD; PRIORITY JOURNAL; RAT; SENSITIZATION; STIMULATION; STRESS; ACUTE DISEASE; ANIMAL; ANIMAL BEHAVIOR; CHRONIC DISEASE; DRUG POTENTIATION; INSTRUMENTAL CONDITIONING; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MENTAL STRESS; PSYCHOLOGICAL ASPECT; WISTAR RAT;

ACUTE DISEASE; ANIMALS; BEHAVIOR, ANIMAL; BENZOMORPHANS; CHRONIC DISEASE; CONDITIONING, OPERANT; INJECTIONS, INTRAVENTRICULAR; MALE; MORPHINE; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; NARCOTICS; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; STRESS, PSYCHOLOGICAL;

EID: 0037076209     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(01)00414-4     Document Type: Article

References (72)

1. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex
2. SCH 23390 blocks drug-conditioned place-preference and place aversion: Anhedonia (lack of reward) or apathy (lack of motivation) after dopamine receptor blockade
3. The role of endorphins in stress evidence and speculations
4. Evidence that the aversive effects of opioid antagonists and κ-agonists are centrally mediated
5. Opposite motivational effects of endogenous opioids in brain and periphery
6. Long-term sensitization of Fos-responsivity in the rat central nervous system after a single stressful experience
7. Chronic stress enhances apomorphine-induced stereotyped behavior in mice: Involvement of endogenous opioids
8. Reciprocal changes in dopamine responsiveness in the nucleus accumbens shell and core and in the dorsal caudate-putamen in rats sensitized to morphine
9. Evidence for a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine
10. Reduced apomorphine induced sedation following chronic stress
11. Chronic stress attenuation of α-adrenoceptor reactivity is reversed by naltrexone
12. Opioid involvement in the adaptive change of 5-HT1a receptors induced by chronic restraint
13. Effect of different restraint schedules on the immobility in the forced swim test: Modulation by an opiate mechanism
14. Anxiolytic-like effect induced by chronic stress is reversed by naloxone pretreatment
15. Gangliosides attenuate stress-induced changes on body weight, motor activity and on the behavioral response to 5-methoxy-N,N-dimethyltryptamine
16. 2 receptors
17. Stress-induced sensitization to amphetamine and morphine psychomotor effects depend on stress-induced corticosterone secretion
18. Social isolation-induced enhancement of the psychomotor effects of morphine depends on corticosterone secretion
19. 2 dopamine and opiate receptors are involved in the restraint stress-induced sensitization to the psychostimulant effects of amphetamine
20. Intracerebroventricular self-injection of morphine in response to pain in rats
21. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats
22. Conditioned place aversion produced by FG 7142 is attenuated by haloperidol
23. High-speed chronoamperometric measurements of mesolimbic and nigrostriatal dopamine release associated with repeated daily stress
24. Role of repeated exposure to morphine in determining its affective properties: Place and taste conditioning studies in rats
25. Food deprivation and stimulant self-administration in rats: Differences between cocaine and D-amphetamine
26. 2 receptor antagonists on the establishment of agonist-induced place conditioning in rats
27. The role of mesoprefrontal dopamine neurons in stress
28. Preexposure sensitizes rats to the rewarding effects of cocaine
29. Changes in brain dopamine and acetylcholine release during and following stress are independent of pituitary-adrenocortical axis
30. Repeated stressful experiences differently affect limbic dopamine release during and following stress
31. Sensitization to repeated enkephalin administration into the ventral tegmental area of the rat. l. Behavioral characterization
32. Enkephalin release into the ventral tegmental area in response to stress: Modulation of mesocorticolimbic dopamine
33. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity
34. Enhancement of some 5-HT-dependent behavioral responses following repeated immobilization in rats
35. Cellular and molecular mechanisms of drug dependence
36. Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine
37. Preexposure to foot-shock sensitizes the locomotor response to subsequent systemic morphine and intra-nucleus accumbens amphetamine
38. Chronic variable stress or chronic morphine facilities immobility in a forced swim test: Reversal by naloxone
39. Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning
40. Reinforcing properties of morphine and naloxone revelead by conditioning place preferences: A procedural examination
41. Aversive properties of naloxone in non-dependent (naive) rats may involve blockade of central β-endorphin
42. Desipramine and restraint stress induced odor conditioning aversion in rats: Suppression by repeated conditioning
43. Effects of local delta and mu opioid receptor activation on basal and stimulated dopamine release in striatum and nucleus accumbens of rat: In vivo electrochemical study
44. Stress- and Pharmacologically induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration
45. Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens
46. Sensitization to stress: The enduring effects of prior stress on amphetamine-induced rotational behavior
47. The neural basis of drug craving: An incentive-sensitization theory of addiction
48. The involvement of nucleus accumbens dopamine in appetitive and aversive motivation
49. An examination of heroin conditioning in preferred and nonpreferred environments and in differentially housed mature and immature rats
50. Immobilization stress-induced oral self-administration and withdrawal in rats: Role of conditioning factors and the effect of stress on "relapse" of opioid drugs
51. Effect of stress on oral morphine fentanyl self-administration in rats
52. Exposure to mild stress enhances the reinforcement efficacy of intravenous heroin self-administration in rats
53. Stress reinstates heroin-seeking in drug-free animals: An effect mimicking heroin, not withdrawal
54. Temporal factors in the effects of restraint stress on morphine-induced behavioral sensitization in the rat
55. Involvement of the mesolimbic dopamine system mediating the aversive effects of opioid antagonists in the rat
56. Examination of the neurochemical substrates mediating the motivational effects of opioids: Role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors
57. Sensitization to the conditioned rewarding effects of morphine: Pharmacology and temporal characterstics
58. Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of μ- and κ-opioid agonists
59. Motivational effects of opioids: Influence of D-1 versus D-2 receptor antagonists
60. Modulation of drug-induced sensitization processes by endogenous opioid systems
61. The effects of opioid peptides on dopamine release in the nucleus accumbens: An in vivo microdialysis study
62. Attenuation by haloperidol of place preference conditioning using food reinforcement
63. Attenuation of heroin reward in rats by destruction of the mesolimbic dopamine system
64. Tolerance and sensitization to the behavioral effects of drugs
65. Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal
66. Stress- and corticosteroid-induced modulation of the locomotor response to morphine in rats
67. Brain adrenergic receptors and resistance to stress
68. Opioids, rewards and addiction: An encounter of biology, psychology and medicine
69. Uncontrollable stress potentiates morphine's rewarding properties
70. Synaptic regulation of mesocorticolimbic dopamine neurons
71. A psychomotor stimulant theory of addiction
72. Effect of social isolation on the reinforcing properties of morphine in the conditioned place preference